MedPath

Fever-based versus guideline-based antibiotic therapy for acute cholangitis following successful endoscopic biliary drainage: a multicenter randomized trial (FANTASTIC trial)

Not Applicable
Conditions
Acute cholangitis
Registration Number
JPRN-UMIN000019814
Lead Sponsor
The University of Tokyo Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
54
Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients with acute pancreatitis 2. Patients with other active concomitant infections (liver abscess, pneumonia, infective endocarditis, etc.) 3. Patients with undrained bile ducts due to multiple biliary strictures. 4. Patients who have undergone biliary stenting or percutaneous biliary drainage. 5. Patients with previous choledochojejunostomy. 6. Patients who have participated in this study. 7. Patients receiving steroid or immunosuppressive agent. 8. Patients who have antipyretic analgesics or NSAIDs within 24 hrs before the diagnosis of cholangitis. 9. Patients receiving chemotherapy. 10. Patients who have received antibiotics within 2 weeks before the diagnosis of cholangitis. 11. Patients considered ineligible for this study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The recurrence rate of cholangitis within 30 days after withdrawal of antibiotic therapy.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath